Stanford and Baylor researchers have discovered an exercise-induced lactate-derived metabolite that mediates the anorexigenic and anti-obesity effects of physical activity.
Researchers at Stanford University have discovered that the absence of a long non coding RNA (lnc122) predisposed mice to high numbers of hepatocellular carcinomas (HCC), and its replacement decreased the risk of HCC.
Stanford inventors have created a novel, interactive, highly scalable computational approach for representing dynamic brain activity as a network for use in clinical settings.
To combat the growing problem of antibiotic resistant bacteria, Stanford researchers have developed nanoclusters comprising a metallic core conjugated to a nucleotide.
Background: Researchers at Stanford have discovered a method to create lattice microneedle structures using high resolution continuous liquid interface printing (CLIP) technology.
Stanford inventors have developed an information theoretic, seizure detection algorithm for electroencephalography (EEG) towards improving diagnosis, management, and treatment of patients with epilepsy.
Stanford scientists pioneer the use of Fibroblast growth factor 17 (Fgf17) to restore memory and treat associated age-related diseases and conditions by rejuvenating oligodendrocytes which are crucial for myelin repair in aging and other neurodegenerative diseases.
Targeted protein degradation is an emerging strategy for the elimination of classically undruggable proteins. Mucins are known to be involved in tumor-progressive pathways but are difficult to target using small molecules and antibodies.
Researchers at Stanford have developed a novel cell-free stem cell derived extracellular vesicle (EV) therapy powered by pulsed focused ultrasound (pFUS) that enhances its therapeutic and bioenergetic effect.